Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with esophageal or stomach cancer through a biopsy, where the cancer can be surgically removed and has not spread to distant parts of the body
- People who are medically cleared for general anesthesia and surgery on the esophagus or stomach
- People who are able to understand information about the study and sign a written consent form
- People who are enrolled in the French social security system
Who may not be able to join:
- People who need emergency surgery due to bleeding, blockage, or a tear or hole in the digestive tract
- People whose cancer has spread to distant parts of the body
- People who have, or are at risk of having, an allergic reaction to indocyanine green (a dye used in the study) or similar fluorescent substances
- People who are pregnant or currently breastfeeding
- People who are currently participating in, or are within a restricted period following, another clinical study
- People who are under legal protection measures ordered by a court
- People who are under guardianship or trusteeship (where another person has been appointed to manage their affairs)
- People who are currently deprived of their liberty (for example, in detention)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Silvana PERRETTA, MD, PhD, Service de Chirurgie Digestive et Endocrinienne, NHC, Strasbourg
Phone: +33 390413608
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the usefulness of ICG fluorescence to guide lymphadenectomy in oncological esogastric resections
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.